Literature DB >> 18625732

The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis.

Celine Cosseau1, Deirdre A Devine, Edie Dullaghan, Jennifer L Gardy, Avinash Chikatamarla, Shaan Gellatly, Lorraine L Yu, Jelena Pistolic, Reza Falsafi, John Tagg, Robert E W Hancock.   

Abstract

Streptococcus salivarius is an early colonizer of human oral and nasopharyngeal epithelia, and strain K12 has reported probiotic effects. An emerging paradigm indicates that commensal bacteria downregulate immune responses through the action on NF-kappaB signaling pathways, but additional mechanisms underlying probiotic actions are not well understood. Our objective here was to identify host genes specifically targeted by K12 by comparing their responses with responses elicited by pathogens and to determine if S. salivarius modulates epithelial cell immune responses. RNA was extracted from human bronchial epithelial cells (16HBE14O- cells) cocultured with K12 or bacterial pathogens. cDNA was hybridized to a human 21K oligonucleotide-based array. Data were analyzed using ArrayPipe, InnateDB, PANTHER, and oPOSSUM. Interleukin 8 (IL-8) and growth-regulated oncogene alpha (Groalpha) secretion were determined by enzyme-linked immunosorbent assay. It was demonstrated that S. salivarius K12 specifically altered the expression of 565 host genes, particularly those involved in multiple innate defense pathways, general epithelial cell function and homeostasis, cytoskeletal remodeling, cell development and migration, and signaling pathways. It inhibited baseline IL-8 secretion and IL-8 responses to LL-37, Pseudomonas aeruginosa, and flagellin in epithelial cells and attenuated Groalpha secretion in response to flagellin. Immunosuppression was coincident with the inhibition of activation of the NF-kappaB pathway. Thus, the commensal and probiotic behaviors of S. salivarius K12 are proposed to be due to the organism (i) eliciting no proinflammatory response, (ii) stimulating an anti-inflammatory response, and (iii) modulating genes associated with adhesion to the epithelial layer and homeostasis. S. salivarius K12 might thereby ensure that it is tolerated by the host and maintained on the epithelial surface while actively protecting the host from inflammation and apoptosis induced by pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625732      PMCID: PMC2519405          DOI: 10.1128/IAI.00188-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4.

Authors:  Loïc Guillot; Samir Medjane; Karine Le-Barillec; Viviane Balloy; Claire Danel; Michel Chignard; Mustapha Si-Tahar
Journal:  J Biol Chem       Date:  2003-11-04       Impact factor: 5.157

2.  Relationship of serum antioxidants to asthma prevalence in youth.

Authors:  Rachel N Rubin; Livia Navon; Patricia A Cassano
Journal:  Am J Respir Crit Care Med       Date:  2003-11-20       Impact factor: 21.405

3.  ArrayPipe: a flexible processing pipeline for microarray data.

Authors:  Karsten Hokamp; Fiona M Roche; Michael Acab; Marc-Etienne Rousseau; Byron Kuo; David Goode; Dana Aeschliman; Jenny Bryan; Lorne A Babiuk; Robert E W Hancock; Fiona S L Brinkman
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

5.  Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium.

Authors:  D E Walsh; C M Greene; T P Carroll; C C Taggart; P M Gallagher; S J O'Neill; N G McElvaney
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

6.  Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species.

Authors:  Whasun O Chung; Beverly A Dale
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Activation of airway epithelial cells by toll-like receptor agonists.

Authors:  Quan Sha; Ai Q Truong-Tran; James R Plitt; Lisa A Beck; Robert P Schleimer
Journal:  Am J Respir Cell Mol Biol       Date:  2004-06-10       Impact factor: 6.914

8.  The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes.

Authors:  Dawn M E Bowdish; Donald J Davidson; David P Speert; Robert E W Hancock
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

9.  N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway.

Authors:  Takao Kataoka; Jürg Tschopp
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 10.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

View more
  88 in total

1.  The role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells.

Authors:  Anastasia Nijnik; Jelena Pistolic; Patricia Cho; Niall C J Filewod; Reza Falsafi; Alexander Ramin; Kenneth W Harder; Robert E W Hancock
Journal:  J Leukoc Biol       Date:  2012-01-13       Impact factor: 4.962

2.  Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellin.

Authors:  Anastasia Nijnik; Jelena Pistolic; Niall C J Filewod; Robert E W Hancock
Journal:  J Innate Immun       Date:  2012-04-17       Impact factor: 7.349

Review 3.  Modulating immunity as a therapy for bacterial infections.

Authors:  Robert E W Hancock; Anastasia Nijnik; Dana J Philpott
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

Review 4.  Oral multispecies biofilm development and the key role of cell-cell distance.

Authors:  Paul E Kolenbrander; Robert J Palmer; Saravanan Periasamy; Nicholas S Jakubovics
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

5.  Comparing the microbiota of the cystic fibrosis lung and human gut.

Authors:  Geraint B Rogers; Mary P Carroll; Lucas R Hoffman; Alan W Walker; David A Fine; Kenneth D Bruce
Journal:  Gut Microbes       Date:  2010-01-29

6.  Tobacco smoking affects bacterial acquisition and colonization in oral biofilms.

Authors:  Purnima S Kumar; Chad R Matthews; Vinayak Joshi; Marko de Jager; Marcelo Aspiras
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

7.  Streptococcus cristatus attenuates Fusobacterium nucleatum-induced cytokine expression by influencing pathways converging on nuclear factor-κB.

Authors:  G Zhang; J D Rudney
Journal:  Mol Oral Microbiol       Date:  2011-01-27       Impact factor: 3.563

8.  Inhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius.

Authors:  Ghalia Kaci; Omar Lakhdari; Joël Doré; S Dusko Ehrlich; Pierre Renault; Hervé M Blottière; Christine Delorme
Journal:  Appl Environ Microbiol       Date:  2011-05-20       Impact factor: 4.792

9.  Protective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection.

Authors:  Tomas Fiedler; Catur Riani; Dirk Koczan; Kerstin Standar; Bernd Kreikemeyer; Andreas Podbielski
Journal:  Appl Environ Microbiol       Date:  2012-12-14       Impact factor: 4.792

10.  Streptococcus pneumoniae nasopharyngeal colonization induces type I interferons and interferon-induced gene expression.

Authors:  Elizabeth A Joyce; Stephen J Popper; Stanley Falkow
Journal:  BMC Genomics       Date:  2009-08-27       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.